Nomura Holdings’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$626K Sell
1,304
-1,159
-47% -$593K ﹤0.01% 1300
2025
Q4
$1.38M Buy
2,463
+1,023
+71% +$581K ﹤0.01% 1228
2025
Q3
$740K Buy
1,440
+139
+11% +$60.7K ﹤0.01% 1490
2025
Q2
$408K Buy
+1,301
New +$391K ﹤0.01% 1177
2025
Q1
Sell
-3,382
Closed -$1.12M 2124
2024
Q4
$1.12M Buy
+3,382
New +$1.15M ﹤0.01% 1400
2021
Q2
Sell
-6,000
Closed -$986K 2211
2021
Q1
$986K Buy
+6,000
New +$918K ﹤0.01% 1103

Other funds holding MEDP

Nomura Holdings's MEDP Position: Q1 2026 in Review

Nomura Holdings reduced its Medpace (MEDP) stake by 47% in Q1 2026, selling an estimated $593K and leaving 1,304 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Nomura Holdings first reported a position in MEDP in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.38M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Nomura Holdings held 1,304 shares of Medpace worth $626K as of Q1 2026.
  • Nomura Holdings sold 1,159 Medpace shares in Q1 2026, an estimated $593K.
  • Medpace made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1300 holding.
  • Nomura Holdings first reported a position in Medpace in Q1 2021 and has held it in 6 quarters since.
  • Nomura Holdings's Medpace position peaked at $1.38M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.